Healthcare provider profile · identity verified

John E Hubner, M.D.

Internal Medicine · TULSA, OK · NPI 1861416190

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	425	117
Levothyroxine Sodium	Levothyroxine Sodium	379	99
Rosuvastatin Calcium	Rosuvastatin Calcium	362	113
Ezetimibe	Ezetimibe	277	78
Atorvastatin Calcium	Atorvastatin Calcium	275	72
Hydrochlorothiazide	Hydrochlorothiazide	192	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	30
Escitalopram Oxalate	Escitalopram Oxalate	185	44
Eliquis	Apixaban	169	32
Montelukast Sodium	Montelukast Sodium	158	55
Gabapentin	Gabapentin	149	39
Meloxicam	Meloxicam	141	41
Omeprazole	Omeprazole	136	39
Torsemide	Torsemide	132	36
Metoprolol Succinate	Metoprolol Succinate	129	39
Zolpidem Tartrate	Zolpidem Tartrate	114	24
Olmesartan Medoxomil	Olmesartan Medoxomil	111	33
Tamsulosin Hcl	Tamsulosin Hcl	109	35
Trazodone Hcl	Trazodone Hcl	109	26
Nebivolol Hcl	Nebivolol Hcl	100	28
Simvastatin	Simvastatin	98	27
Clonazepam	Clonazepam	95	17
Lorazepam	Lorazepam	94	23
Arexvy	Rsvpref3 Antigen/As01e/Pf	88	88
Finasteride	Finasteride	78	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	77	55
Duloxetine Hcl	Duloxetine Hcl	75	19
Donepezil Hcl	Donepezil Hcl	72	15
Prednisone	Prednisone	72	43
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	71	19
Synthroid	Levothyroxine Sodium	70	18
Famotidine	Famotidine	68	24
Azithromycin	Azithromycin	67	58
Alendronate Sodium	Alendronate Sodium	64	18
Jardiance	Empagliflozin	63	18
Memantine Hcl	Memantine Hcl	62	12
Doxycycline Hyclate	Doxycycline Hyclate	60	44
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	37
Temazepam	Temazepam	58	14
Bupropion Xl	Bupropion Hcl	57	15
Clopidogrel	Clopidogrel Bisulfate	57	15
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	55	55
Tramadol Hcl	Tramadol Hcl	55	11
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	55	14
Ramipril	Ramipril	54	14
Lisinopril	Lisinopril	53	12
Methylprednisolone	Methylprednisolone	53	46
Xarelto	Rivaroxaban	53	suppressed
Metformin Hcl	Metformin Hcl	52	16
Mounjaro	Tirzepatide	52	suppressed
Alprazolam	Alprazolam	51	11
Chlorthalidone	Chlorthalidone	51	15
Citalopram Hbr	Citalopram Hydrobromide	51	15
Fluoxetine Hcl	Fluoxetine Hcl	51	13
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Raloxifene Hcl	Raloxifene Hcl	49	suppressed
Benazepril Hcl	Benazepril Hcl	48	13
Esomeprazole Magnesium	Esomeprazole Magnesium	48	13
Potassium Chloride	Potassium Chloride	48	16
Pantoprazole Sodium	Pantoprazole Sodium	47	14
Valsartan	Valsartan	46	15
Paxlovid	Nirmatrelvir/Ritonavir	45	43
Allopurinol	Allopurinol	44	12
Metoprolol Tartrate	Metoprolol Tartrate	44	12
Repatha Sureclick	Evolocumab	44	suppressed
Ozempic	Semaglutide	43	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	suppressed
Eszopiclone	Eszopiclone	42	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	42	12
Losartan Potassium	Losartan Potassium	36	11
Pravastatin Sodium	Pravastatin Sodium	36	13
Celecoxib	Celecoxib	35	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Myrbetriq	Mirabegron	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	29	23
Mupirocin	Mupirocin	29	29
Estradiol	Estradiol	28	12
Spironolactone	Spironolactone	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Irbesartan	Irbesartan	26	suppressed
Amoxicillin	Amoxicillin	25	16
Fluticasone Propionate	Fluticasone Propionate	25	12
Furosemide	Furosemide	25	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Fenofibrate	Fenofibrate,micronized	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	14
Topiramate	Topiramate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Ondansetron Odt	Ondansetron	21	16
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Cephalexin	Cephalexin	19	14
Colchicine	Colchicine	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Premarin	Estrogens, Conjugated	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	15
Diazepam	Diazepam	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	14
Mirtazapine	Mirtazapine	17	suppressed
Testosterone	Testosterone	17	suppressed
Atenolol	Atenolol	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	16	suppressed
Digoxin	Digoxin	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Linzess	Linaclotide	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Indapamide	Indapamide	14	suppressed
Modafinil	Modafinil	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Clonidine	Clonidine	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Lamotrigine	Lamotrigine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	12
Pregabalin	Pregabalin	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error